Close
AI in Healthcare & Pharma Summit Boston 2026

Navitas Brings End-to-End R&D Solutions to the Generic Drug Industry

Navitas Life Sciences, a TAKE Solutions Enterprise, provides services and technology to deliver "first to file" results to generic drug companies around the globe,...

Capricor Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for CAP-1002

Capricor Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to conduct a new clinical...

Aimovig Phase 3 STRIVE Data Published In The New England Journal Of Medicine Demonstrate Significant, Sustained Efficacy In Migraine Prevention

Amgen announced that the New England Journal of Medicine (NEJM) published positive results from the six-month Phase 3 STRIVE study evaluating Aimovig™ (erenumab) versus...

Merck Receives FDA Approval for ISENTRESS , in Combination with Other Antiretroviral Agents, for the Treatment of HIV-1 Infection

Merck , known as MSD outside the United States and Canada announced that the U.S. FDA has approved ISENTRESS® (raltegravir), the company’s integrase inhibitor,...

Surge in RNAscope and BaseScope Assay publications now includes pharma, biotech and new research areas – and use as a core assay

Advanced Cell Diagnostics (ACD), a Bio-Techne brand, is celebrating a milestone in the adoption of its RNAscope® in situ hybridization (ISH) technology. Reaching 1,000...

Median Technologies inks a collaboration agreement with Memorial Sloan Kettering Cancer Center for a study dealing with prostate cancer

Median Technologies, The Imaging Phenomics Company® (Paris:ALMDT) announces today that the company has signed a collaboration agreement with the New York City based Memorial...

Takeda Initiates Phase 1 Clinical Trial of Zika Vaccine Candidate

Takeda Pharmaceutical Company Limited announced that its purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate (TAK-426) has progressed into a Phase 1 clinical trial,...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...